We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
US judge’s decision is setback to strategy to shield financial damage from lawsuits
Governments have promised to tackle the crisis for 25 years, but it’s never an election winner
Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases
System for transcribing legislation into 24 languages overwhelmed by deluge of initiatives
Information Commissioner’s Office calls for new regulation to avoid ethical breaches over handling of brain data
Semaglutide should be made more accessible to help patients and relieve pressure on hospitals, say ministers
Pharmaceutical group says parts of law are unconstitutional
Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected
Unsupervised generative AI could harm users and no one should risk their mental stability with ad hoc experimentation
Drugmaker seeks opportunities due to ageing population and burgeoning biotech industry
Nobel Prize winner who discovered the cause of cervical cancer in humans
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
Regulators might put up an obstacle given the Swedish group’s sizeable footprint in the sector
Move for veterinary pharma company would represent one of biggest UK private equity deals this year
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
The tobacco company can justifiably claim expertise in developing alternative products that smokers will actually try
Generative AI has uses for the legal and health professions but is also a trap for the unwary
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?
Appeals court says some liability releases are ‘appropriate’ under US bankruptcy law
Despite increasing staff numbers, services in England are struggling to match pre-pandemic treatment levels
Rise in temperatures has led to the spread of disease-carriers to higher altitudes
International Edition
